ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 09 Nov 2020
Last Applicant/ Owned by
9805 Burgen Ave
Los Angeles
CA
90048
Serial Number
88107543 filed on 06th Sep 2018
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
GB GEMELLI BIOTECH
Medical testing for diagnostic or treatment purposes; providing medical information to physicians, patients, researchers, and medical professionals in the form of reports in the field of medical diagnostics, clinical diagnostics, medical research, clinical research, drug development, drug development research, biotechnology, and genetics
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical testing for diagnostic or treatment purposes; providing medical information to physicians, patients, researchers, and medical professionals in the form of reports in the field of medical diagnostics, clinical diagnostics, medical research, clinical research, drug development, drug development research, biotechnology, and genetics
First Use Date in General
31st Oct 2018
First Use Date in Commerce
31st Oct 2018
Mark Details
Serial Number
No 88107543
Mark Type
No Service Mark
Attorney Docket Number
No 56112-TM1002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Nov 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 09th Nov 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 28th Apr 2020 | SU - FINAL REFUSAL - WRITTEN |
| 28th Apr 2020 | FINAL REFUSAL E-MAILED |
| 28th Apr 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 20th Apr 2020 | TEAS EXTENSION RECEIVED |
| 10th Apr 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 10th Apr 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 09th Apr 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 18th Jan 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |